Pharma’s response to the COVID-19 pandemic and its impact on public image
Pharmaceutical companies have historically struggled with negative public perception. In January 2020, before the COVID-19 pandemic, only...
Pharma’s response to the COVID-19 pandemic and its impact on public image
Merck Targets Autoimmune Treatment in Pandion Therapeutics
Wall Street Bets vs. Melvin Capital
The Case for Supernus Pharmaceuticals
Annual Biotech Investment Fantasy League Results
Reinventing the vaccine
Aducanumab takes Biogen stock for a wild ride
Gilead stock price fluctuates as remdesivir earns FDA approval
The pros of investing in an orphan drug company
Merck’s August performance drives PPIP’s growth
PPIP Rides Success of AstraZeneca
Due Diligence Presentations
Industry News Update: 4/6
Industry News Update: 3/29
Industry News Update: 3/22
Industry News Update: 3/15
Industry News Update: 3/7
Industry News Update: 3/1
Industry News Update: 2/14
Industry News Update